Liquid blood test for mature B-cell tumors
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how a “liquid biopsy,” a test done on blood, may help in people with mature B-cell tumors. It mainly checks whether you can take part and complete the planned study procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult age 18 or older.
- You have a confirmed diagnosis of a mature B-cell tumor.
- Your diagnosis matches the World Health Organization (WHO) 2008 criteria.
- You’re willing and able to follow the study’s scheduled visits and procedures.
- You have signed informed consent (you agree to join after learning about the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
This study creates lab models from blood samples of people with specific mature B-cell blood cancers (CLL, SMZL, HCL) to test new immune and combination treatments. This research may help find more personalized therapies for these diseases.
This study looks at “cell-free DNA,” meaning tiny bits of DNA found in blood, in people with mature B-cell lymphoma. It may help doctors understand the disease better and how blood tests could be used to monitor it.
This study collects blood and may also use existing tumor tissue to help develop a liquid biopsy blood test for people with solid (non-blood) cancers. You may qualify if you have a current cancer with tumor in the body and can provide blood samples at set visits.
This trial studies “liquid biopsies,” which are blood tests, to help learn about specific cancers in children. It may help doctors monitor cancer and guide treatment using less invasive tests.
This study tests whether a liquid biopsy (a simple blood test) can help monitor germ cell tumors (a type of testicular cancer) that have spread or have a high risk of coming back. It may help guide treatment decisions without needing repeated tissue biopsies.
Hear when a new Mature B-Cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.